# Medicare-Drug-Costs-Analysis

## Overview
Analyzing Medicare Part D spending growth from 2019-2023 to asnwer: Which manufacturers and products are driving costs? This project examines spending by drug and manufacturer, pricing changes across units/ claims/ beneficiaries, brand-generic shifts, outlier medications, and fastest-growing drugs by price-per-dose. 

## ğŸ¯ Project Goals

To answer the following question:
Where are Medicare drug costs rising faster, and which manufacturers and products are driving the growth?

Sub-questions:
1. What is total spend by year and drug? By manufacturer?
2. How is average spend per dose unit changing? Per claim? Per beneficiary?
3. What is the brand vs. generic share and how is it shifting?
4. Which products trigger the outlier flag and why?
5. Which drugs have the highest 2019-2023 CAGR in price-per-dose?


## ğŸ—‚ Dataset

**Dataset**: Medicare Quarterly Part D Spending by Drug 
**Source**: [Data.CMS.gov](https://data.cms.gov/summary-statistics-on-use-and-payments/medicare-medicaid-spending-by-drug/medicare-part-d-spending-by-drug)


## ğŸ› ï¸ Tools and Methods

Languages & Libraries:
- Python
- Pandas, NumPy
- Matplotlib, Seaborn
- Scikit-learn
- Jupyter Notebook

Tools:
- Git & GitHub
- VS Code

## ğŸ“Œ Key Insights

